Cargando…

Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer

BACKGROUND: Molecular and epidemiological evidence demonstrate that altered gene expression and single nucleotide polymorphisms in the apoptotic pathway are linked to many cancers. Yet, few studies emphasize the interaction of variant apoptotic genes and their joint modifying effects on prostate can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lavender, Nicole A, Rogers, Erica N, Yeyeodu, Susan, Rudd, James, Hu, Ting, Zhang, Jie, Brock, Guy N, Kimbro, Kevin S, Moore, Jason H, Hein, David W, Kidd, La Creis R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355002/ https://www.ncbi.nlm.nih.gov/pubmed/22546513 http://dx.doi.org/10.1186/1755-8794-5-11

Ejemplares similares

Toll-Like Receptor (TLR)-Associated Sequence Variants and Prostate Cancer Risk among Men of African Descent
por: Rogers, Erica N., et al.
Publicado: (2013)

Evaluation of Oxidative Stress Response Related Genetic Variants, Pro-oxidants, Antioxidants and Prostate Cancer
por: Lavender, Nicole, et al.
Publicado: (2015)

Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study
por: Kidd, LaCreis R, et al.
Publicado: (2012)

Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among Men of African Descent: A case-control study
por: Lavender, Nicole A, et al.
Publicado: (2009)

IRAK4 and TLR3 Sequence Variants may Alter Breast Cancer Risk among African-American Women
por: Yeyeodu, Susan T., et al.
Publicado: (2013)

8q24 sequence variants in relation to prostate cancer risk among men of African descent: A case-control study
por: Benford, Marnita L, et al.
Publicado: (2010)

No Association Between Variant N-acetyltransferase Genes, Cigarette Smoking and Prostate Cancer Susceptibility Among Men of African Descent
por: Kidd, La Creis Renee, et al.
Publicado: (2011)

The impact of genetic variants in inflammatory-related genes on prostate cancer risk among men of African Descent: a case control study
por: Jones, Dominique Z, et al.
Publicado: (2013)

Neuroendocrine and Aggressive-Variant Prostate Cancer
por: Spetsieris, Nicholas, et al.
Publicado: (2020)

Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells
por: Jones, Dominique Z., et al.
Publicado: (2018)

Biomarkers of Aggressive Prostate Cancer at Diagnosis
por: Boehm, Brock E., et al.
Publicado: (2023)

Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent
por: Rebbeck, Timothy R., et al.
Publicado: (2013)

Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
por: Montironi, Rodolfo, et al.
Publicado: (2020)

Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation
por: Merkens, Lina, et al.
Publicado: (2022)

The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness
por: Hormaechea-Agulla, Daniel, et al.
Publicado: (2017)

Aggressive variant prostate cancer: A case report and literature review
por: Weng, Xiang-Tao, et al.
Publicado: (2023)

A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer
por: Brown, Landon C., et al.
Publicado: (2022)

Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
por: Nguyen-Dumont, Tú, et al.
Publicado: (2021)

Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers
por: Soundararajan, Rama, et al.
Publicado: (2018)

Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput N-Glycan Profiling
por: Gilgunn, Sarah, et al.
Publicado: (2020)

Identification of Germline Genetic Variants that Increase Prostate Cancer Risk and Influence Development of Aggressive Disease
por: Saunders, Edward J., et al.
Publicado: (2021)

Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) Components
por: Soundararajan, Rama, et al.
Publicado: (2022)

Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer
por: von Amsberg, Gunhild, et al.
Publicado: (2022)

Association of prostate volume with incidence and aggressiveness of prostate cancer
por: Al-Khalil, Shadi, et al.
Publicado: (2016)

Serum Fucosylated Prostate-specific Antigen (PSA) Improves the Differentiation of Aggressive from Non-aggressive Prostate Cancers
por: Li, Qing Kay, et al.
Publicado: (2015)

miRNAs associated with prostate cancer risk and progression
por: Luu, Hung N., et al.
Publicado: (2017)

Characterisation of microbial communities within aggressive prostate cancer tissues
por: Yow, Melissa A., et al.
Publicado: (2017)

Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype
por: Simpson, Benjamin S., et al.
Publicado: (2020)

A Case of Leptomeningeal Carcinomatosis from Aggressive Metastatic Prostate Cancer
por: Carroll, Ryan David, et al.
Publicado: (2019)

Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer
por: Pardella, Elisa, et al.
Publicado: (2022)

Association of a Common Variant at 10q26 and Benign Prostatic Hyperplasia Aggressiveness in Han Chinese Descent
por: Gu, Xin, et al.
Publicado: (2013)

Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial–mesenchymal Transition in Aggressive Variant Prostate Cancers
por: Mitra Ghosh, Taraswi, et al.
Publicado: (2023)

FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer
por: Baker, M J, et al.
Publicado: (2008)

Blood-Based Biomarkers of Aggressive Prostate Cancer
por: Liong, Men Long, et al.
Publicado: (2012)

Src: Marker or Actor in Prostate Cancer Aggressiveness
por: Vlaeminck-Guillem, Virginie, et al.
Publicado: (2014)

Serum lipid profiles and aggressive prostate cancer
por: Li, Yanjing, et al.
Publicado: (2015)

Evaluation of protein biomarkers of prostate cancer aggressiveness
por: Rizzardi, Anthony E, et al.
Publicado: (2014)

Aggressive angiomyxoma of the prostate: A case report
por: Zhu, Zhirong, et al.
Publicado: (2018)

ANO7 is associated with aggressive prostate cancer
por: Kaikkonen, Elina, et al.
Publicado: (2018)

Mitochondrial mutations drive prostate cancer aggression
por: Hopkins, Julia F., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3khcua4p8u9nuds4atnuhj6l6l